- 收听数
- 0
- 性别
- 保密
- 听众数
- 5
- 最后登录
- 2019-1-9
- QQ
 - UID
- 4916
- 阅读权限
- 10
- 帖子
- 297
- 精华
- 0
- 在线时间
- 86 小时
- 注册时间
- 2013-7-22

- 科研币
- 0
- 速递币
- 429
- 娱乐币
- 661
- 文献值
- 10
- 资源值
- 0
- 贡献值
- 0
|
10速递币
题名 | Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. | 作者 | Lawitz E1, Sulkowski MS2, Ghalib R3, Rodriguez-Torres M4, Younossi ZM5, Corregidor A6, DeJesus E7, Pearlman B8, Rabinovitz M9, Gitlin N10, Lim JK11, Pockros PJ12, Scott JD13, Fevery B14, Lambrecht T15, Ouwerkerk-Mahadevan S14, Callewaert K14, Symonds WT16, Picchio G17, Lindsay KL17, Beumont M14, Jacobson IM18. | 杂志 | Lancet. 2014 Jul 26. pii: S0140-6736(14)61036-9. doi: 10.1016/S0140-6736(14)61036-9. [Epub ahead of print] | 年|卷|期 | Lancet. 2014 Jul 26. pii: S0140-6736(14)61036-9. doi: 10.1016/S0140-6736(14)61036-9. [Epub ahead of print] | 页码 | Lancet. 2014 Jul 26. pii: S0140-6736(14)61036-9. doi: 10.1016/S0140-6736(14)61036-9. [Epub ahead of print] | 链接 | http://www.sciencedirect.com/science/article/pii/S0140673614610369 |
|
-
总评分: 速递币 -10
查看全部评分
|